bibliographic entry 6662368 [be/6662368]
https://w3id.org/oc/corpus/be/6662368

is a

• bibliographic reference

content

• Fleischmann, R, Cutolo, M, Genovese, MC. Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs, Arthritis Rheum, 2012, 64, 617, 629, PMID: 21952978

references

• https://w3id.org/oc/corpus/br/528651